Entry |
|
Name |
Probenecid (JP18/USP/INN); Benemid (TN) |
Product |
|
Generic |
|
Formula |
C13H19NO4S
|
Exact mass |
285.1035
|
Mol weight |
285.3593
|
Structure |
|
Simcomp |
|
Class |
Musculo-skeletal system agent
DG02042 Uricosurics
|
Remark |
Therapeutic category: | 3942 |
Product (mixture): | D11574<US> |
|
Efficacy |
Gout suppressant, Uricosuric |
Disease |
Gout and gouty arthritis [DS: H01532] |
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M04 ANTIGOUT PREPARATIONS
M04A ANTIGOUT PREPARATIONS
M04AB Preparations increasing uric acid excretion
M04AB01 Probenecid
D00475 Probenecid (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antigout Agents
Probenecid
D00475 Probenecid (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
394 Gout preparations
3942 Probenecids
D00475 Probenecid (JP18/USP/INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02042 Uricosurics
D00475 Probenecid
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00475 Probenecid
D00475 Probenecid tablets
|
Other DBs |
|
KCF data |
ATOM 19
1 C8y C 23.5954 -17.3956
2 S4a S 22.3946 -16.6962
3 C8x C 23.5954 -18.7944
4 C8x C 24.8135 -16.6962
5 N1c N 21.1824 -17.3897
6 O3c O 21.3922 -15.6995
7 O3c O 23.3797 -15.6995
8 C8x C 24.8135 -19.4996
9 C8x C 26.0257 -17.3956
10 C1b C 19.9702 -16.6904
11 C1b C 21.1824 -18.7827
12 C8y C 26.0257 -18.7944
13 C1b C 18.7578 -17.3782
14 C1b C 19.9702 -19.4762
15 C6a C 27.2439 -19.4996
16 C1a C 17.5456 -16.6845
17 C1a C 19.9702 -20.8750
18 O6a O 27.2439 -20.8984
19 O6a O 28.4561 -18.7944
BOND 19
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 2
6 2 7 2
7 3 8 1
8 4 9 2
9 5 10 1
10 5 11 1
11 8 12 2
12 10 13 1
13 11 14 1
14 12 15 1
15 13 16 1
16 14 17 1
17 15 18 1
18 15 19 2
19 9 12 1
|